Eli Lilly And Stock Alpha and Beta Analysis

LLY Stock  USD 745.95  4.82  0.64%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Eli Lilly and. It also helps investors analyze the systematic and unsystematic risks associated with investing in Eli Lilly over a specified time horizon. Remember, high Eli Lilly's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Eli Lilly's market risk premium analysis include:
Beta
0.71
Alpha
0.21
Risk
1.63
Sharpe Ratio
0.17
Expected Return
0.28
Please note that although Eli Lilly alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Eli Lilly did 0.21  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Eli Lilly and stock's relative risk over its benchmark. Eli Lilly has a beta of 0.71  . As returns on the market increase, Eli Lilly's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eli Lilly is expected to be smaller as well. At this time, Eli Lilly's Enterprise Value Over EBITDA is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 51.15 in 2024, whereas Book Value Per Share is likely to drop 6.16 in 2024.

Eli Lilly Quarterly Cash And Equivalents

2.38 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Eli Lilly Backtesting, Eli Lilly Valuation, Eli Lilly Correlation, Eli Lilly Hype Analysis, Eli Lilly Volatility, Eli Lilly History and analyze Eli Lilly Performance.

Eli Lilly Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Eli Lilly market risk premium is the additional return an investor will receive from holding Eli Lilly long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Eli Lilly. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Eli Lilly's performance over market.
α0.21   β0.71

Eli Lilly expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Eli Lilly's Buy-and-hold return. Our buy-and-hold chart shows how Eli Lilly performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Eli Lilly Market Price Analysis

Market price analysis indicators help investors to evaluate how Eli Lilly stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eli Lilly shares will generate the highest return on investment. By understating and applying Eli Lilly stock market price indicators, traders can identify Eli Lilly position entry and exit signals to maximize returns.

Eli Lilly Return and Market Media

The median price of Eli Lilly for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 is 757.31 with a coefficient of variation of 7.27. The daily time series for the period is distributed with a sample standard deviation of 53.33, arithmetic mean of 733.92, and mean deviation of 43.01. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
 
Eli Lilly dividend paid on 15th of February 2024
02/15/2024
 
Eli Lilly dividend paid on 8th of March 2024
03/08/2024
1
Amazon Pharmacy Expands Same-Day Delivery to New York, Los Angeles
03/26/2024
2
Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study
04/01/2024
3
1 Warren Buffett Index Fund Could Turn 400 per Month Into 904,100, With Help From the Magnificent Seven Stocks
04/05/2024
4
Entos Pharmaceuticals to Present at the 2024 Bloom Burton Co. Healthcare Investor Conference
04/09/2024
5
Riassunto Gli innovativi biomarcatori per il punteggio Z relativo al grasso AMRA Medical mostrano che il trattamento con tirzepatide associato a un potenziale e...
04/10/2024
6
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimers disease diagnosis
04/11/2024
7
Anti-obesity Drugs market is estimated to grow at a CAGR of 21.2 percent by 2034 Visiongain
04/12/2024
8
Fen-Phen Again Why Ozempic and New Weight-Loss Drugs Are Different
04/15/2024
9
Catch up on the days news Mayorkas impeachment fails, dementia risks, NBA player banned
04/17/2024

About Eli Lilly Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Eli or other stocks. Alpha measures the amount that position in Eli Lilly has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.01230.01070.0077550.007367
Price To Sales Ratio8.8511.5615.3816.15

Eli Lilly Upcoming Company Events

As portrayed in its financial statements, the presentation of Eli Lilly's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Eli Lilly's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Eli Lilly's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Eli Lilly. Please utilize our Beneish M Score to check the likelihood of Eli Lilly's management manipulating its earnings.
6th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Eli Lilly

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Eli Lilly technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Eli Lilly technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eli Lilly trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...